450 Brookline Avenue
Boston, MA 02215
United States
Harvard University - Dana-Farber Cancer Institute
Non-Small Cell Lung Cancer, immunotherapy, pembrolizumab, Tumor microenvironment, Tumor immunophenotype, Older adults
Pancreatic neuroendocrine tumours, Streptozotocin, Chemotherapy, Advanced disease, Objective response rate, Progression-free survival, Meta-analysis, Treatment outcomes